ARTV

Artiva Biotherapeutics, Inc. Common Stock

57 hedge funds and large institutions have $213M invested in Artiva Biotherapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+9
Holders Change %
+18.75%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
18
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
GFM
51
GF Fund Management
China
$5.14K +$5.14K +510 New
AB
52
Amalgamated Bank
New York
$5K
AWM
53
Avior Wealth Management
Nebraska
$2.26K +$2.26K +224 New
SCM
54
Sterling Capital Management
North Carolina
$2.18K +$1.87K +185 +597%
Carson Wealth (CWM LLC)
55
Carson Wealth (CWM LLC)
Nebraska
$1K +$1K +132 New
Nisa Investment Advisors
56
Nisa Investment Advisors
Missouri
$433 +$433 +43 New
GI
57
GAMMA Investing
California
$151 +$151 +15 New
SO
58
STRS Ohio
Ohio
-$40.2K -2,600 Closed